期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 99, 期 5, 页码 485-493出版社
WILEY
DOI: 10.1002/cpt.353
关键词
-
资金
- Concern Foundation
- Hyundai Hope on Wheels grant
- William Lawrence & Blanche Hughes Foundation grant
- Jean Perkins Foundation grant
- Nautica Malibu Triathlon Funds
- STOP Cancer grant
- Hugh and Audy Lou Colvin Foundation grant
- Alex's Lemonade Stand Foundation grant
- National Cancer Institute [P30CA014089]
The most common cause of cancer relapse is drug resistance, acquired or intrinsic, which strongly limits the efficacy of both conventional and new targeted chemotherapy. MicroRNAs (miRNAs) are a growing, large family of short noncoding RNAs frequently dysregulated in malignancies. Although the mechanism of miRNA-mediated drug resistance is not fully understood, an increasing amount of evidence suggests their involvement in the acquisition of tumor cell drug resistance, pointing towards the need for novel and more innovative therapeutic approaches. Use of antagomiRs or mimics can modulate specific miRNAs in order to restore gene networks and signaling pathways, perhaps optimizing chemotherapies by increasing cancer cell sensitivity to drugs. The aim of this review is to provide a state-of-the-art scenario with regard to the most recent discoveries in the field of miRNAs involved in the process of resistance to cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据